Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?

Simply Wall StFeb 6 05:01 ET

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

BusinesswireFeb 3 07:01 ET

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Yahoo FinanceJan 30 08:08 ET

Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating

TipRanksJan 27 01:15 ET · Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 12, 2024 16:05 ET

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks Nov 14, 2024 08:40 ET